$4.30
-0.26 (-5.70%)
XenoPort, Inc. (NASDAQ:XNPT)
CAPS Rating:
A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.
RSS Headlines
Fool UK